>
Danaher logo

DHR PR A - Danaher Share Price

$2207.78 111.8  5.3%

Sector
Healthcare
Size
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 7321
Bullish
Bearish
Unlock DHR PR A Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 01st Jan 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 01 October 2021, DanaherCorporation revenues increased 37% to $21.31B. Net incomeapplicable to common stockholders excluding extraordinaryitems increased 92% to $4.44B. Revenues reflect LifeSciences segment increase of 2% to $7.37B. Net incomebenefited from Life Sciences segment income increase of 70%to $2.12B, Other segment loss decrease of 50% to $135M.Dividend per share increased from $0.53 to $0.60.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

DHR PR A Revenue Unlock DHR PR A Revenue

Net Income

DHR PR A Net Income Unlock DHR PR A Revenue

Normalised EPS

DHR PR A Normalised EPS Unlock DHR PR A Revenue

PE Ratio Range

DHR PR A PE Ratio Range Unlock DHR PR A Revenue

Dividend Yield Range

DHR PR A Dividend Yield Range Unlock DHR PR A Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
DHR PR A EPS Forecasts Unlock DHR PR A Revenue
Profile Summary

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through three segments: Life Sciences, which offers a range of instruments and consumables that are used by customers to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines; Diagnostics, which offers analytical instruments, reagents, consumables, software and services, and Environmental & Applied Solutions, which offers products and services that help protect important resources and keep global food and water supplies safe. Its business research and development, manufacturing, sales, distribution, service and administrative facilities are located in over 60 countries.

Directors
Last Annual January 1st, 1970
Last Interim January 1st, 1970
Incorporated October 3, 1986
Public Since December 10, 1969
No. of Shareholders: 2,372
No. of Employees: 67,000
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange New York Stock Exchange
Shares in Issue
Free Float (0.0%)
Eligible for
× ISAs
SIPPs
DHR PR A Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for DHR PR A
Upcoming Events for DHR PR A
Wednesday 1st December, 2021
Danaher Corp at Evercore ISI HealthCONx Virtual Conference
Thursday 30th December, 2021
Dividend For DHR_pb.N - 12.5000 USD
Thursday 30th December, 2021
Dividend For DHR_pa.N - 11.8750 USD
Wednesday 26th January, 2022 Estimate
Q4 2021 Danaher Corp Earnings Release
Wednesday 20th April, 2022 Estimate
Q1 2022 Danaher Corp Earnings Release
Thursday 5th May, 2022 Estimate
Danaher Corp Annual Shareholders Meeting
Similar to DHR PR A
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.